Category Archives: Pharmaceutical

Novo Holdings Acquires Life Science Commercialization Firm MKG

MedicalKnowedgeGroup (MKG) companies address the business needs of biopharmaceutical companies through the provision of network-mapping analytics, patient-finding analytics, and multi-channel marketing solutions

GoodRx Acquires vitaCare Prescription Services to Help Facilitate Prescription Process

GoodRx’s acquisition of vitaCare Prescription Services will help more patients receive their prescriptions in an efficient, affordable, and transparent manner, and stay on their prescribed therapies as long as appropriate

Highmark’s Strategy to Contain Drug Costs Includes an Increasing Number of Outcome-Based Contracts

Pharmaceutical manufacturers and payers have developed a number of agreements under which reimbursement is contingent on specific outcomes over the last few years

FamilyWize’s Online Drug Discount Care Program Growing Rapidly

FamilyWize, a Bethlehem, Pa.-based company devoted to getting the best prices for their consumers, think they can play a big role in helping patients to reduce their prescription costs.

Pharmacy Benefit Manager Market Continues to Evolve

Pharmacy Benefit Manager Market Continues to Evolve. Recent consolidation in the pharmacy benefit manager (PBM) industry has resulted in major market share divided by the three market leaders: Express Scripts, CVS Health (Caremark), and OptumRx (UnitedHealth Group). PBMs remain searching for a value proposition beyond drug distribution with their employer clients. As long as PBMs […]

Managed care pharmacy survey findings 2016

Managed care pharmacy survey findings 2016 Managed Healthcare Executive September 26, 2016 To identify the top managed care pharmacy challenges and what your peers are doing about them, Managed Healthcare Executive, in partnership with Access Market Intelligence and the National Institute of Collaborative Healthcare, conducted its first-ever pharmacy survey during the second quarter of 2016. […]

Section 1332 Opportunity for Pharmaceutical Manufacturers

Section 1332 Opportunity for Pharmaceutical Manufacturers – by Gregory Judd, CEBS   A funny thing happened while pharmaceutical manufacturers were going through wrenching strategic and organizational changes during the past 6 or 7 years. The Affordable Care Act. Ok, so ACA is not all THAT funny. But it IS big, and has exerted a sort of […]